Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preclinical toxicity, pharmacokinetics and metabolism of SM-9018 described

March 10, 1997

Agents for CNS disorders described by American Home Products

March 10, 1997

Vyrex and Immune Response form collaboration

March 7, 1997

AIT-082 enters clinic

March 7, 1997

Teva receives tentative approval for ketorolac tromethamine

March 7, 1997

Cypros receives SBIR grant

March 6, 1997

Neuroimmunophilin ligand shows promise for Parkinson's disease

March 6, 1997

Glaxo Wellcome evaluates melatonin agonist

March 6, 1997

Abbott describes AK inhibitor with anticonvulsant/neuroprotective effects

March 6, 1997

Pharmacia & Upjohn claims antimigraine agents

March 6, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...